Quarterly Result13 Aug 2025, 05:42 pm
Aarey Drugs & Pharmaceuticals Ltd. Announces Q1 2025 Financial Results with 157.53% YoY Revenue Growth
AI Summary
Aarey Drugs & Pharmaceuticals Ltd. has announced its unaudited financial results for the quarter ended 30th June, 2025. The company's revenue from operations stands at Rs. 12,591.18 Lakhs, marking a significant growth of 157.53% compared to the same period last year. The results have been reviewed by the Audit Committee and taken on record by the Board of Directors.
Key Highlights
- Revenue from operations for Q1 2025 stands at Rs. 12,591.18 Lakhs, a YoY growth of 157.53%.
- The company operates only in one segment: Manufacturing and Trading of Drugs & Pharmaceuticals and allied activities.
- The figures of the previous year and/or period have been regrouped wherever necessary.
- The unaudited financial results have been prepared in accordance with Companies (Indian Accounting Standard) Rules, 2015.
- The company's MD, Mihir R. Ghatalia, has confirmed the accuracy and compliance of the financial results.